This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (30)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • HIV/AIDS  • Pregnancy and Breast Feeding  • Alert me on articles by topic

The Case for Restraint

Jeffrey S. A. Stringer, MD; Dwight J. Rouse, MD; Robert L. Goldenberg, MD

JAMA. 1999;281:1946-1949.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The introduction of viral protease inhibitors into combination antiretroviral regimens has dramatically changed human immunodeficiency virus (HIV) therapeutics. Capable of suppressing measurable viral loads to undetectable levels, combination therapy has improved clinical status¹ and prolonged survival^2-3 for many patients in the developed world and is now firmly established as standard of care in the United States.⁴ Recently, in an effort to afford these same benefits to HIV-infected pregnant women, the US Public Health Service has recommended that combination antiretroviral therapy be offered during pregnancy as well.⁵ As an associated effect, several centers that have implemented these recommendations have observed perinatal HIV transmission rates approaching zero among women receiving combination agents^6-9; by comparison, the HIV transmission risk in untreated, non–breast-feeding women in the developed world is 14% to 25%,¹⁰ which can be reduced to as low as . . . [Full Text of this Article]

Evidence on Use of Prophylactic Cesarean Delivery

Author Affiliations: Center for Research on Women's Health, Department of Obstetrics and Gynecology, University of Alabama at Birmingham.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Medical Neglect: A Child-Focused View
Dubowitz et al.
Arch Pediatr Adolesc Med 2002;156:297-298.
FULL TEXT  

Combination antiretroviral therapy in 100 HIV-1-infected pregnant women
Bucceri et al.
Hum Reprod 2002;17:436-441.
ABSTRACT | FULL TEXT  

When Parents Reject Interventions to Reduce Postnatal Human Immunodeficiency Virus Transmission
Wolf et al.
Arch Pediatr Adolesc Med 2001;155:927-933.
ABSTRACT | FULL TEXT  

Recent advances: Obstetrics
Roberts
BMJ 2000;321:33-35.
FULL TEXT  

Prevention of Perinatal HIV Infection: Cause For Optimism
AIDS Clin Care 1999;1999:1-1.
FULL TEXT  

Cost effectiveness analysis of antenatal HIV screening in United Kingdom
Ades et al.
BMJ 1999;319:1230-1234.
ABSTRACT | FULL TEXT  

SHOULD WOMEN WITH HUMAN IMMUNODEFICIENCY VIRUS BE DELIVERED BY CESAREAN?
Star et al.
Obstet Gynecol 1999;94:799-801.
ABSTRACT | FULL TEXT  

Update in Infectious Diseases
Bartlett
ANN INTERN MED 1999;131:273-280.
FULL TEXT  

Can Perinatal HIV Infection Be Eliminated in the United States?
Mofenson
JAMA 1999;282:577-579.
FULL TEXT